OR WAIT null SECS
Four reasons why data is important whether you’re a practice owner or employed physician - and four ways to incorporate data into the selection of drugs and devices for patients.
For the first time, fewer than 50 percent of U.S. physicians own their own practices. That number will continue to increase as more physicians pursue hospital employment over private practice, according to the American Medical Association. However, health systems need to remember that employed physicians do not spontaneously become cost and quality champions. Instead, health system leaders need to dig deeper to understand the unique clinical and financial factors as well as key priorities that inform and motivate physician decision-making, regardless of employment model. This is particularly true since physicians are responsible for up to 85 percent of a health system’s cost and quality decisions.
One of the greatest and mostly costly areas of variation that physicians control is the selection of the drugs and devices used to treat patients. Lumere recently surveyed nearly 300 physicians to gain insight into what drives their perceptions of clinical variation and the factors that influence their choices of drugs and devices. The results were clear: Physicians crave meaningful data related to cost and variation.
These survey results confirm my profound belief that hospital leaders need to forge deeper partnerships with their doctors to address cost and care quality as well as create the best value for their patients. Here are at four key takeaways from the survey to help better align physicians and administrators.
About 90 percent of respondents felt increasing physician access to cost data would improve quality of care, yet only 40 percent said their hospital had taken steps to do so. The majority of respondents also said they believe physicians should be active participants in creating the evidence-based clinical protocols, practice guidelines and best practices used at their organizations.
Physicians want the total picture. This includes the clinical evidence to choose cost-effective drug and device alternatives without negatively affecting outcomes. Survey respondents with exposure to cost data, variation data and practice guidelines generally found this information more influential than other factors (e.g., industry representatives, costs and hospital preferences or contracts) in their decision to switch drugs or device vendors. This was particularly true for more veteran physicians and those with private practice experience who had greater exposure to managing cost information.
The survey results show that employed physicians are not inherently more likely to make device selection decisions that benefit their health system’s financial performance. For example, employed and independent surgical specialists reported equally that device cost was “very” or “extremely” influential to these decisions. Additionally, the results suggest that physicians, independent of their health system’s specific alignment models, are more likely to be influenced by device cost when they share in the device management savings (e.g., through a gainsharing model) than when the hospital alone realizes the savings.
Compared to independent physicians who were not part of any alignment model, physicians participating in accountable care organizations, bundled payment and co-management agreements were slightly less likely to be influenced by device cost when the health system saves.
While physicians are more likely to be influenced by device cost when they share in savings resulting from the product switch, these results overall suggest that shared savings might only have a weak effect on physician decision-making.
Lumere’s analysis shows that physicians who have personal experience managing financial performance are more likely to understand the impact of cost-related data, regardless of whether the patient, physician practice or the health system is ultimately responsible for the cost. Additionally, when Lumere looked at the relationship between the level of physician experience with managing provider costs and cost data, we saw that veteran doctors generally found cost data more influential than less-experienced physicians.
The survey takeaways all point to an important question: How should independent physicians approach hospital leaders to encourage greater transparency in data sharing? Here are three steps to get started.
Asking physicians to simply reduce costs can end a conversation before it even starts. To get physicians more involved, analyze cost drivers within the clinical context of improving patient care - that’s the language physicians speak best.
The truth is, many health systems don’t know where to start. Between various data collection systems, varied stakeholder requests and the overwhelming amount of available information, building a robust mechanism for data sharing can be a daunting task. By simply opening the lines of communication, you can begin to overcome any lack of knowledge and institutional awareness about communicating data. Ensuring that physicians have a strong voice in determining which data to share will help create systemwide alignment.
Care quality, patient outcomes and cost data should be benchmarked on current evidence-based guidelines and captured in a consistent and usable format. Organizational transparency matters: Health system leaders should acknowledge physicians’ recognition of the relationship between continuity of care and quality of care. Everyone will gain an advantage by openly and transparently engaging with physicians and fostering a culture that uses data analytics to improve the value of care.
Many health systems are just beginning the journey of managing the abundance of data involved in improving the care they provide. While initial experiences with collecting and analyzing data has been cumbersome, this will improve. Cost and quality data have the potential to dramatically change how physicians practice medicine, since having access to that data leads to improved treatment choices and better outcomes. Meanwhile, patients will have a greater choice in their care and a clearer understanding of what is the best option, both clinically and economically.
As healthcare moves toward value-driven care, physicians and health systems must collaborate to increase care quality and drive cost effectiveness. Taking active steps now to increase physician involvement to meet these goals will only help health systems and physicians do all they can to meet these quality improvement goals together.
John Cherf, MD, MPH, MBA, is chief medical officer of Lumere, a provider of utilization management, physician practice-pattern analysis and pharmacy management solutions.